Scholarlink

<p>Most of the available preclinical Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH) models fail to resemble metabolic comorbidities and liver fibrosis. To establish a standard MASLD/MASH model, we characterized some morphological, biochemical, and transcriptomic features in a Western diet-induced MASLD model in mice, depicting its similarities to the corresponding human disease. Male C57BL/6J mice received a hypercaloric diet containing sucrose, saturated fat, and cholesterol-rich chow, and high sugar solution for 24 weeks. This model featured a distinct MASH phenotype with obesity, impaired glucose metabolism, hypercholesterolemia, extensive macro and microvesicular, liver steatosis, and slight-to-moderate pericellular/perisinusoidal fibrosis, which was in keeping with the increased hepatic levels of IL-6 and TNF-α, and upregulation of 18 collagen subunit genes (as <i>Col1a1</i>, <i>Col1a2</i>, <i>Col3a1</i>, <i>Col5a2</i>, <i>Col4a1</i>, <i>Col6a3</i>, <i>Col14a1</i>, <i>Col6a2</i>, <i>Col5a1</i>), 34 cytokines or chemokines or related receptors-coding genes (as <i>Il15</i>, <i>Cxcl9</i>, <i>Ccl22</i>), 18 TNF-related genes (as <i>Tnfaip8l3</i>, <i>Tnfrsf21</i>, <i>Tnfaip8</i>, <i>Tnfrfs12a</i>) and 12 metalloproteinase/tissue inhibitors of metalloproteinases-related genes (as <i>Mmp2</i>, <i>Mmp7</i>). The downregulated genes were negative regulators of gluconeogenesis, insulin secretion, and lipid biosynthesis, most belonging to the major urinary protein (MUP) family. The computational analysis of human samples revealed a similarity between our bioassay and human steatohepatitis, with the upregulation of fibrosis- and inflammation-associated orthologs (<i>COL1A1</i>, <i>COL1A2</i>, <i>COL3A1</i>, <i>COL5A2</i>, <i>COL4A1</i>, <i>COL6A3</i>, <i>COL14A1</i>, <i>COL6A2</i>, <i>COL5A1</i>, <i>TNFAIP8L3</i>, <i>TNFRSF21</i>, <i>TNFAIP8</i>, <i>TNFRFS12A</i>, <i>IL15</i>, <i>CXCL9</i>, <i>CCL22</i>, <i>MMP2</i>, <i>MMP7</i>). Our mouse model may be applied as a standard MASH translational bioassay, providing valuable insights into the inflammatory/fibrosis axis of this chronic disease, from the pathogenesis to therapeutic intervention.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease

  • 期刊论文

  • 发表日期：

    2025年5月20日

查看全文
  • Guilherme Ribeiro Romualdo,
  • Letícia C. Valente,
  • Gabriel P. Bacil,
  • Luana Riechelmann-Casarin,
  • Antônio R. B. da Fonseca,
  • Miguel W. Fornes,
  • Luís F. Barbisan

摘要

Most of the available preclinical Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH) models fail to resemble metabolic comorbidities and liver fibrosis. To establish a standard MASLD/MASH model, we characterized some morphological, biochemical, and transcriptomic features in a Western diet-induced MASLD model in mice, depicting its similarities to the corresponding human disease. Male C57BL/6J mice received a hypercaloric diet containing sucrose, saturated fat, and cholesterol-rich chow, and high sugar solution for 24 weeks. This model featured a distinct MASH phenotype with obesity, impaired glucose metabolism, hypercholesterolemia, extensive macro and microvesicular, liver steatosis, and slight-to-moderate pericellular/perisinusoidal fibrosis, which was in keeping with the increased hepatic levels of IL-6 and TNF-α, and upregulation of 18 collagen subunit genes (as Col1a1, Col1a2, Col3a1, Col5a2, Col4a1, Col6a3, Col14a1, Col6a2, Col5a1), 34 cytokines or chemokines or related receptors-coding genes (as Il15, Cxcl9, Ccl22), 18 TNF-related genes (as Tnfaip8l3, Tnfrsf21, Tnfaip8, Tnfrfs12a) and 12 metalloproteinase/tissue inhibitors of metalloproteinases-related genes (as Mmp2, Mmp7). The downregulated genes were negative regulators of gluconeogenesis, insulin secretion, and lipid biosynthesis, most belonging to the major urinary protein (MUP) family. The computational analysis of human samples revealed a similarity between our bioassay and human steatohepatitis, with the upregulation of fibrosis- and inflammation-associated orthologs (COL1A1, COL1A2, COL3A1, COL5A2, COL4A1, COL6A3, COL14A1, COL6A2, COL5A1, TNFAIP8L3, TNFRSF21, TNFAIP8, TNFRFS12A, IL15, CXCL9, CCL22, MMP2, MMP7). Our mouse model may be applied as a standard MASH translational bioassay, providing valuable insights into the inflammatory/fibrosis axis of this chronic disease, from the pathogenesis to therapeutic intervention.